Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 101, Issue 2-3, 2006, Pages 118-126

  Weiss, Juergen M ^a   König, Stephan J ^b   Polack, Stephan ^a   Emons, Günter ^c   Schulz, Klaus Dieter ^b   Diedrich, Klaus ^a   Ortmann, Olaf ^d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Estradiol; GnRH antagonists; LH secretion; Progesterone

Indexed keywords

CETRORELIX; ESTRADIOL; GONADORELIN AGONIST; LUTEINIZING HORMONE; PROGESTERONE; TRIPTORELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; DESENSITIZATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG INHIBITION; FEMALE; GONADOTROPIN SECRETING CELL; HORMONE INHIBITION; INCUBATION TIME; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; NONHUMAN; OVARY HYPERSTIMULATION; RAT;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; LUTEINIZING HORMONE; LUTEOLYTIC AGENTS; OVARY; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; STEROIDS; TRIPTORELIN;

EID: 33748160054     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.06.009     Document Type: Article

References (58)

1. Stojilkovic S.S., and Catt K.J. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog. Horm. Res. 50 (1995) 161-205
2. Conn P.M., and Crowley W.F. Gonadotropin-releasing hormone and its analogues. N. Engl. J. Med. 324 2 (1991) 93-103
3. Loumaye E., and Catt K.J. Homologous regulation of gonadotropin-releasing hormone receptors in cultured pituitary cells. Science 215 4535 (1982) 983-985
4. Rivier J.E., Porter J., Rivier C.L., et al. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J. Med. Chem. 29 10 (1986) 1846-1851
5. Albano C., Smitz J., Camus M., Riethmuller-Winzen H., Van Steirteghem A., and Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil. Steril. 67 5 (1997) 917-922
6. Diedrich K., Diedrich C., Santos E., et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod. 9 5 (1994) 788-791
7. Felberbaum R.E., Reissmann T., Küpker W., et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur. J. Obstet. Gynecol. Reprod. Biol. 61 2 (1995) 151-155
8. Fujimoto V.Y., Monroe S.E., Nelson L.R., Downey D., and Jaffe R.B. Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray. Fertil. Steril. 67 3 (1997) 469-473
9. Rabinovici J., Rothman P., Monroe S.E., Nerenberg C., and Jaffe R.B. Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women. J. Clin. Endocrinol. Metab. 75 5 (1992) 1220-1225
10. Reissmann T., Diedrich K., Comaru-Schally A.M., and Schally A.V. Introduction of LHRH-antagonists into the treatment of gynaecological disorders. Hum. Reprod. 9 5 (1994) 769
11. Ortmann O., Weiss J.M., and Diedrich K. Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action. Reprod. Biomed. Online 5 3 (2002) 1-7 Suppl. 1
12. Schally A.V. LH-RH analogues. I. Their impact on reproductive medicine. Gynecol. Endocrinol. 13 6 (1999) 401-409
13. Weiss J.M., Diedrich K., and Ludwig M. Gonadotropin-releasing hormone antagonists: pharmacology and clinical use in women. Treat. Endocrinol. 1 (2002) 281-291
14. Stanger J.D., and Yovich J.L. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br. J. Obstet. Gynaecol. 92 4 (1985) 385-393
15. Kolibianakis E.M., Tarlatzis B., and Devroey P. GnRH antagonists in IVF. Reprod. Biomed. Online 10 6 (2005) 705-712
16. Weiss J.M., Ludwig M., Ortmann O., and Diedrich K. GnRH antagonists in the treatment of infertility. Ann. Med. 35 7 (2003) 512-522
17. Al Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum. Reprod. 17 4 (2002) 874-885
18. Albano C., Felberbaum R.E., Smitz J., et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study group. Hum. Reprod. 15 3 (2000) 526-531
19. Ludwig M., Katalinic A., and Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-anal. Arch. Gynecol. Obstet. 265 4 (2001) 175-182
20. Olivennes F., Belaisch-Allart J., Emperaire J.C., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil. Steril. 73 2 (2000) 314-320
21. Brann D.W., and Mahesh V.B. Regulation of gonadotropin secretion by steroid hormones. Front Neuroendocrinol. 12 (1991) 165-170
22. Ortmann O., Merelli F., Stojilkovic S.S., Schulz K.D., Emons G., and Catt K.J. Modulation of calcium signaling and LH secretion by progesterone in pituitary gonadotrophs and clonal pituitary cells. J. Steroid Biochem. Mol. Biol. 48 1 (1994) 47-54
23. Clayton R.N. Mechanism of GnRH action in gonadotrophs. Hum. Reprod. 3 4 (1988) 479-483
24. Clayton R.N., and Catt K.J. Regulation of pituitary gonadotropin-releasing hormone receptors by gonadal hormones. Endocrinology 108 3 (1981) 887-895
25. Gregg D.W., Schwall R.H., and Nett T.M. Regulation of gonadotropin secretion and number of gonadotropin-releasing hormone receptors by inhibin, activin-A, and estradiol. Biol. Reprod. 44 4 (1991) 725-732
26. Kolibianakis E.M., Zikopoulos K., Smitz J., et al. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum. Reprod. 19 7 (2004) 1525-1529
27. Ortmann O., Sturm R., Knuppen R., and Emons G. Weak estrogenic activity of phenol red in the pituitary gonadotroph: re-evaluation of estrogen and antiestrogen effects. J. Steroid Biochem. 35 1 (1990) 17-22
28. Ortmann O., Bakhit M., Bloh P., Schulz K.D., and Emons G. Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and alpha T3-1 gonadotrophs. J. Steroid Biochem. Mol. Biol. 54 3-4 (1995) 101-109
29. Bouvier M., Hausdorff W.P., De Blasi A., et al. Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature 333 6171 (1988) 370-373
30. Tobin A.B. Phosphorylation of phospholipase C-coupled receptors. Pharmacol. Ther. 75 2 (1997) 135-151
31. Sealfon S.C., Weinstein H., and Millar R.P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr. Rev. 18 2 (1997) 180-205
32. Stojilkovic S.S., Reinhart J., and Catt K.J. Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocr. Rev. 15 4 (1994) 462-499
33. Willars G.B., Heding A., Vrecl M., et al. Lack of a C-terminal tail in the mammalian gonadotropin-releasing hormone receptor confers resistance to agonist-dependent phosphorylation and rapid desensitization. J. Biol. Chem. 274 42 (1999) 30146-30153
34. Heding A., Vrecl M., Bogerd J., et al. Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics. J. Biol. Chem. 273 19 (1998) 11472-11477
35. Blomenrohr M., Bogerd J., Leurs R., et al. Differences in structure-function relations between nonmammalian and mammalian gonadotropin-releasing hormone receptors. Biochem. Biophys. Res. Commun. 238 2 (1997) 517-522
36. Anderson L., McGregor A., Cook J.V., Chilvers E., and Eidne K.A. Rapid desensitization of GnRH-stimulated intracellular signalling events in alpha T3-1 and HEK-293 cells expressing the GnRH receptor. Endocrinology 136 11 (1995) 5228-5231
37. 2+ responses in alpha T3-1 gonadotropes. J. Biol. Chem. 276 5 (2001) 3123-3129
38. Kaiser U.B., Conn P.M., and Chin W.W. Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr. Rev. 18 1 (1997) 46-70
39. Lalloz M.R., Detta A., and Clayton R.N. Gonadotropin-releasing hormone desensitization preferentially inhibits expression of the luteinizing hormone beta-subunit gene in vivo. Endocrinology 122 4 (1988) 1689-1694
40. Lerrant Y., Kottler M.L., Bergametti F., Moumni M., Blumberg-Tick J., and Counis R. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary. Endocrinology 136 7 (1995) 2803-2808
41. Ayalon D., Farhi Y., Comaru-Schally A.M., et al. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat. Neuroendocrinology 58 2 (1993) 153-159
42. Gromoll J., Weinbauer G.F., Simoni M., and Nieschlag E. Effects of antiandrogens and ethane dimethane sulphonate (EDS) on gene expression, free subunits, bioactivity and secretion of pituitary gonadotrophins in male rats. Mol. Cell Endocrinol. 91 1-2 (1993) 119-125
43. Murase M., Uemura T., Gao M., Inada M., Funabashi T., and Hirahara F. GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects. Endocr. J. 52 1 (2005) 131-137
44. Zhou W., Rodic V., Kitanovic S., et al. A locus of the gonadotropin-releasing hormone receptor that differentiates agonist and antagonist binding sites. J. Biol. Chem. 270 32 (1995) 18853-18857
45. Loumaye E., Wynn P.C., Coy D., and Catt K.J. Receptor-binding properties of gonadotropin-releasing hormone derivatives. Prolonged receptor occupancy and cell-surface localization of a potent antagonist analog. J. Biol. Chem. 259 20 (1984) 12663-12671
46. Horvath J.E., Toller G.L., Schally A.V., Bajo A.M., and Groot K. Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats. Proc. Natl. Acad. Sci. U. S. A. 101 14 (2004) 4996-5001
47. Pinski J., Lamharzi N., Halmos G., et al. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Endocrinology 137 8 (1996) 3430-3436
48. Halmos G., Schally A.V., Pinski J., Vadillo-Buenfil M., and Groot K. Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix. Proc. Natl. Acad. Sci. U. S. A. 93 6 (1996) 2398-2402
49. Kovacs M., Schally A.V., Csernus B., and Rekasi Z. Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH. Proc. Natl. Acad. Sci. U. S. A. 98 4 (2001) 1829-1834
50. Kovacs M., and Schally A.V. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc. Natl. Acad. Sci. U. S. A. 98 21 (2001) 12197-12202
51. Neill J.D., Duck L.W., Sellers J.C., et al. Potential role for a regulator of G protein signaling (RGS3) in gonadotropin-releasing hormone (GnRH) stimulated desensitization. Endocrinology 138 2 (1997) 843-846
52. Smith M.A., and Vale W.W. Desensitization to gonadotropin-releasing hormone observed in superfused pituitary cells on Cytodex beads. Endocrinology 108 3 (1981) 752-759
53. Emons G., Nill J., Sturm R., and Ortmann O. Effects of progesterone on gonadotropin-releasing hormone receptor concentration in cultured estrogen-primed female rat pituitary cells. J. Steroid Biochem. Mol. Biol. 42 8 (1992) 831-839
54. Ortmann O., Johannsen K., Knuppen R., and Emons G. Acute effects of oestradiol and progesterone on melittin- and gonadotrophin-releasing hormone-induced LH secretion. J. Endocrinol. 132 2 (1992) 251-259
55. Araki S., Chikazawa K., Motoyama M., Ijima K., Abe N., and Tamada T. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone. J. Clin. Endocrinol. Metab. 60 3 (1985) 590-598
56. Simard J., Labrie C., Hubert J.F., and Labrie F. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland. Mol. Endocrinol. 2 9 (1988) 775-784
57. Broekmans F.J., Bernardus R.E., Berkhout G., and Schoemaker J. Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR. Gynecol. Endocrinol. 6 3 (1992) 153-161
58. Matt D.W., Tedeschi M.L., and Sayles T.E. Alterations in gonadotropin secretion in middle-aged persistent-estrous rats following LHRH agonist treatment. Neuroendocrinology 56 6 (1992) 780-787